Johnson & Johnson on Wednesday issued new financial guidance after spinning out the consumer-health company Kenvue While its earnings and sales projections were lowered on an absolute basis,…
Read more Johnson & Johnson Maintains Dividend After Kenvue SpinoutJohnson & Johnson $35 billion exchange offer for Kenvue that expired last Friday was substantially oversubscribed. The result is that participating J&J holders will be able to convert…
Read more J&J Investors Can Convert Only a Fraction of Shares Into Kenvue StockJohnson and Johnson $40 billion exchange offer for shares in Kenvue is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to…
Read more J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/kenvue-jnj-stock-price-exchange-offer-e85c3c90 Updated Aug. 15, 2023…
Read more J&J Investors Must Decide If They Want Kenvue StockKenvue Inc. shares KVUE, +18.86% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.24% spinoff, with consumer brands including Tylenol, Band-Aid and…
Read more Kenvue stock opens 16% above IPO, valuing the company at $47.7 billionIntraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time…
Read more KVUE Stock Price | Kenvue Inc. Stock Quote (U.S.: NYSE) | MarketWatch
